In a 58-year-old man with gastroesophageal reflux disease, hypertension, type 2 diabetes mellitus, vertigo, and obesity who presents with popping sounds, muffled hearing, and decreased tympanic membrane mobility due to eustachian tube dysfunction, which of his existing conditions should be treated to prevent recurrence of these ear symptoms?

Management of Gastroesophageal Reflux Disease is Most Likely to Prevent Future Occurrences

Treatment of gastroesophageal reflux disease (GERD) is the most appropriate intervention to prevent recurrence of this patient's eustachian tube dysfunction symptoms. The patient presents with classic eustachian tube dysfunction (popping sounds, muffled hearing, decreased tympanic membrane mobility), and ear disease is a recognized extraesophageal manifestation of GERD 1.

Clinical Reasoning

This patient's presentation fits the pattern of extraesophageal reflux (EER) affecting the middle ear. The 2023 AGA guidelines explicitly list ear disease among the possible extraesophageal manifestations of GERD 1. The pathophysiology involves either:

• Direct mechanism: Refluxate (containing acid, pepsin, bile acids) reaches the nasopharynx and eustachian tube opening, causing inflammation and mucosal edema that impairs tube function
• Reflex mechanism: Vagally-mediated inflammatory responses triggered by distal esophageal acid exposure 1

Recent prospective studies provide compelling evidence:

• A 2025 study demonstrated that 72% of patients with LPRD and asymptomatic middle ear dysfunction showed improved audiometric thresholds after 8 weeks of anti-reflux therapy, with 38% showing complete tympanogram normalization 2
• Another 2025 study showed significant improvement in Eustachian Tube Dysfunction Questionnaire scores (16.20 to 10.40, p<0.001) following 8 weeks of PPI therapy 3

Why Not the Other Conditions?

Obesity deserves consideration, as one case report showed ET dysfunction improvement with weight loss 4. However, this represents a single case report versus the stronger evidence for GERD management. Additionally, rapid weight loss can paradoxically cause patulous eustachian tube dysfunction 5. The obesity-GERD connection is well-established 6, 7, making GERD treatment the more direct intervention.

Hypertension, type 2 diabetes, and vertigo have no established causal relationship with eustachian tube dysfunction in the medical literature.

Recommended Management Approach

1. Initiate twice-daily PPI therapy (e.g., omeprazole 40 mg BID or equivalent) for 8-12 weeks 1, 2, 3

2. Implement lifestyle modifications concurrently:

   • Elevate head of bed
   • Avoid late-night meals
   • Reduce dietary triggers
   • Address obesity (BMI 35) as a contributing factor to GERD 6

3. Reassess at 8 weeks: Evaluate both ear symptoms and reflux symptoms

4. If symptoms persist despite adequate PPI trial:

   • Consider objective testing with ambulatory pH monitoring off therapy 1
   • Evaluate for alternative causes of ET dysfunction 8
   • Consider ENT referral for multidisciplinary evaluation 1

Critical Pitfalls to Avoid

• Don't dismiss the GERD connection just because the patient lacks typical heartburn symptoms—50-60% of EER patients don't have classic reflux symptoms 1
• Don't continue empiric PPI indefinitely without objective confirmation if symptoms don't improve after 12 weeks 1
• Don't ignore medication non-adherence: This patient admits to not taking his prescribed medications, which likely includes his GERD therapy—addressing adherence is essential
• Don't pursue aggressive weight loss without monitoring, as rapid weight reduction can cause patulous ET dysfunction 5

The evidence strongly supports that optimizing GERD management through medication adherence, PPI therapy, and lifestyle modification represents the most evidence-based approach to preventing recurrence of this patient's eustachian tube dysfunction 2, 3.